Getinge’s iCast covered stent system expands U.S. offering with additional sizes
Getinge has received U.S. FDA Premarket Approval (PMA) for additional sizes of its iCast covered stent system, expanding treatment options for patients with occlusive disease. The approval includes a new 10 mm diameter by 59 mm length, new 32 mm lengths, and new 12 mm large diameter options.
These newly approved sizes enable physicians to treat a broader range of vessel and lesion diameters and lengths, increasing procedural flexibility and expanding access to the iCast covered stent system for more patients across the U.S.
”We are excited to bring this important portfolio expansion to the U.S. market,” said Chad Carlton, Vice President Endovascular Solutions at Getinge. “Physicians outside the U.S. have long benefitted from a broader size offering when treating patients with our Advanta V12 covered stent system, which features an identical device design to the iCast covered stent. We are pleased to now offer these additional sizes to U.S. physicians within the iCast covered stent product family.”
Ongoing collaboration with Cook Medical
The iCast covered stent system, including the newly approved sizes, will continue to be distributed in the U.S. through Getinge’s collaboration with Cook Medical. The new sizes are expected to be available for order early this spring.
Discover Getinge’s iCast covered stent system >>
Media contact:
Jennifer Bianco, Senior Director ACT Communication
Phone: (973) 709-7000
Email: jennifer.bianco@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
